The lawsuits began piling in October 2021 — about four months after the recall — according to court documents. Since then, the FDA has reported more than 105,000 injuries and 385 deaths related to the recall.
Philips Respironics filed for a partial settlement agreement, which is subject to the court’s approval, to offer between $50 and $1,500 to each customer, according to The New York Times.
In a news release, the company said the decision is not an admission of liability or guilt.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
